MiR-338-5p can promote the proliferation, migration and invasion of bladder cancer cells by targeting TSHZ3

doi:10.11958/20221910

Abstract

Abstract:

Objective To investigate the mechanism of miR-338-5p regulating the proliferation, migration and invasion of bladder cancer cells by targeting TSHZ3. Methods The expression of miR-338-5p in 33 samples of bladder cancer tissue and paracancerous tissue was detected by qRT-PCR. Bladder cancer T24 and UM-UC-3 cells were transfected with mimics-NC, miR-338-5p mimics, inhibitor-NC and miR-338-5p inhibitor, and the transfection efficiency was detected by qRT-PCR. CCK-8 assay was used to detect the effect of overexpression or knockdown of miR-338-5p on the proliferation of bladder cancer cells. Transwell assay was used to detect the effect of miR-338-5p on migration and invasion of bladder cancer cells. The potential target genes of miR-338-5p were predicted by TargetScan, miRDB and Targetminer databases, and TSHZ3 was chosen for the target gene. The targeting relationship between miR-338-5p and TSHZ3 was verified by dual-luciferase reporter gene assay and Western blot assay. miR-338-5p mimics and TSHZ3 overexpression plasmids were co-transfected in bladder cancer cells, and the proliferation, migration and invasion of cells were detected by CCK-8 and Transwell assays. Western blot assay was used to detect the overexpression of miR-338-5p or TSHZ3 against Wnt/ β-catenin signaling pathway. Results miR-338-5p was significantly upregulated in bladder cancer (P<0.05). Overexpression of miR-338-5p increased the proliferation, migration and invasion of bladder cancer cells (P<0.05), while transfection of miR-338-5p inhibitor decreased the proliferation, migration and invasion of bladder cancer cells (P<0.05). Bioinformatics analysis and the dual-luciferase reporter gene assay showed that there was a targeting relationship between miR-338-5p and TSHZ3. The rescue experiment showed that co-transfection of miR-338-5p mimics and TSHZ3 overexpression plasmid partially eliminated the promoting effect of overexpression of miR-338-5p on the proliferation, migration and invasion of bladder cancer cells (P<0.05). Western blot results showed that overexpression of miR-338-5p significantly decreased the expression level of TSHZ3 protein and increased Wnt3a and β-catenin protein expression levels (P<0.05). In addition, overexpression of TSHZ3 reduced Wnt3a and β-catenin protein expression levels (P<0.05). Conclusion miR-338-5p is upregulated in bladder cancer, and promotes the proliferation, migration and invasion of bladder cancer by targeting TSHZ3 expression. The mechanism may be related to the activation of Wnt/β-catenin signaling pathway.

Key words: urinary bladder neoplasms, cell proliferation, cell movement, neoplasm invasiveness, miR-338-5p, TSHZ3, Wnt/β-catenin

CLC Number:

R737.14

Figures/Tables 17

Fig.1 The expression of miR-338-5p in normal urothelial cells and bladder cancer cells

Fig.2 Transfection efficiency of overexpression and inhibition of miR-338-5p

Fig.3 Effect of overexpression of miR-338-5p on cell proliferation detected by CCK-8 assay

Fig.4 Effect of inhibition of miR-338-5p on cell proliferation detected by CCK-8 assay

Tab.1 Comparison of the number of migrated and invaded cells between the four groups

组别	T24
组别	迁移	侵袭
mimics-NC组	136.00±3.61	138.34±3.51
miR-338-5p mimics组	200.67±4.51	202.67±8.50
t	19.400^＊＊	12.110^＊＊
inhibitor-NC组	327.00±6.56	305.67±8.02
miR-338-5p inhibitor组	252.33±6.51	211.33±8.33
t	14.000^＊＊	14.132^＊＊
组别	UM-UC-3
组别	迁移	侵袭
mimics-NC组	237.00±5.57	291.67±7.02
miR-338-5p mimics组	387.67±5.13	468.33±3.06
t	34.645^＊＊	39.950^＊＊
inhibitor-NC组	344.33±5.03	375.00±9.00
miR-338-5p inhibitor组	146.00±7.21	159.67±4.51
t	39.064^＊＊	37.051^＊＊

Fig.5 Effects of overexpression of miR-338-5p on migration and invasion of bladder cancer cells (crystal violet staining, ×200)

Fig.6 Effects of inhibition of miR-338-5p on migration and invasion of bladder cancer cells (crystal violet staining, ×200)

Fig.7 Nucleotide sequences complementary to miR-338-5p in the 3'-UTR of TSHZ3

Tab.2 Comparison of the luciferase activity between the two groups

组别	T24		UM-UC-3
组别	TSHZ3-wt	TSHZ3-mut	TSHZ3-wt	TSHZ3-mut
mimics-NC组	1.00±0.25	0.94±0.05	1.06±0.07	1.02±0.11
miR-338-5p mimics组	0.54±0.07	0.91±0.03	0.49±0.04	0.96±0.04
t	10.473^＊＊	1.067	12.173^＊＊	0.888

Fig.8 Effect of overexpression of miR-338-5p on TSHZ3 mRNA expression

Fig. 9 Effect of overexpression of miR-338-5p on TSHZ3 protein level

Fig.10 The mRNA expression of TSHZ3 in normal urothelial cells and bladder cancer cells

Fig.11 Cell viability detected by CCK-8 assay in each group

Tab.3 Comparison of the number of migrated and invaded cells between the three groups

组别		T24
组别		迁移	侵袭
mimics-NC组		144.33±4.51	151.00±6.00
miR-338-5p mimics组		309.67±5.51^a	356.33±8.50^a
miR-338-5p mimics+TSHZ3组		204.67±7.02^b	214.67±9.50^b
F		630.003^＊＊	500.471^＊＊
组别	UM-UC-3
组别	迁移		侵袭
mimics-NC组	173.67±5.03		101.00±6.00
miR-338-5p mimics组	332.67±4.73^a		284.33±6.51^a
miR-338-5p mimics+TSHZ3组	255.00±7.94^b		213.00±6.56^b
F	514.087^＊＊		633.505^＊＊

Fig.12 Migration and invasion of each group of cells (crystal violet staining, ×200)

Fig.13 Effect of overexpression of miR-338-5p on the protein level of Wnt3a and β-catenin

Fig.14 Effect of overexpression of TSHZ3 on the protein level of Wnt3a and β-catenin

References 13

[1]	TAHERI M, SHIRVANI-FARSANI Z, GHAFOURI-FARD S, et al. Expression profile of microRNAs in bladder cancer and their application as biomarkers[J]. Biomed Pharmacother, 2020, 131:110703. doi:10.1016/j.biopha.2020.110703.
[2]	WU H, LI F, ZHU R. miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer[J]. Acta Biochim Biophys Sin (Shanghai), 2021, 53(3):304-316. doi:10.1093/abbs/gmaa170.
[3]	LI Y, HUANG Y, QI Z, et al. MiR-338-5p promotes glioma cell invasion by regulating TSHZ3 and MMP2[J]. Cell Mol Neurobiol, 2018, 38(3):669-677. doi:10.1007/s10571-017-0525-x.
[4]	CHU C A, LEE C T, LEE J C, et al. MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway[J]. EBioMedicine, 2019, 43:270-281. doi:10.1016/j.ebiom.2019.04.010.
[5]	LENIS A T, LEC P M, CHAMIE K, et al. Bladder cancer: a review[J]. JAMA, 2020, 324(19):1980-1991. doi:10.1001/jama.2020.17598.
[6]	LI Y, SUN L, GUO X, et al. Frontiers in bladder cancer genomic research[J]. Front Oncol, 2021, 11:670729. doi:10.3389/fonc.2021.670729.
[7]	HE B, ZHAO Z, CAI Q, et al. MiRNA-based biomarkers,therapies,and resistance in cancer[J]. Int J Biol Sci, 2020, 16(14):2628-2647. doi:10.7150/ijbs.47203.
[8]	LIN W C, CHEN L H, HSIEH Y C, et al. miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2[J]. Carcinogenesis, 2019, 40(7):883-892. doi:10.1093/carcin/bgy189.
[9]	WEI X, ZHU J, ZHANG Y, et al. miR-338-5p-ZEB2 axis in diagnostic,therapeutic predictive and prognostic value of gastric cancer[J]. J Cancer, 2021, 12(22):6756-6772. doi:10.7150/jca.58249.
[10]	LONG J, LUO J, YIN X. MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82[J]. Biomed Pharmacother, 2018, 102:1195-1202. doi:10.1016/j.biopha.2018.03.075.
[11]	XU L, ZHU S, TANG A, et al. LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/beta-catenin signaling pathway[J]. Inflamm Res, 2021, 70(2):217-227. doi:10.1007/s00011-020-01432-z.
[12]	朱奕, 刘宏伟, 柳建军. TSHZ3在膀胱癌组织中的表达及其对膀胱癌细胞生物学功能的影响[J]. 现代肿瘤医学, 2022, 30(16):2880-2885.
	ZHU Y, LIU H W, LIU J J. Expression of TSHZ3 in bladder cancer tissues and its effect on the biological function of bladder cancer cells[J]. Modern Oncology, 2022, 30(16):2880-2885. doi:10.3969/j.issn.1672-4992.2022.16.003.
[13]	YAO X, MAO Y, WU D, et al. Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion,migration,proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and targeting the Wif1/Wnt8/beta-catenin axis[J]. Cancer Lett, 2021, 512:38-50. doi:10.1016/j.canlet.2021.04.030.

[1]	YANG Xiaofang, JIA Xinyan, FENG Wenjun. MiR-181a-5p regulates the proliferation and apoptosis of glomerular mesangial cells in lupus nephritis mice through HMGB1/NF-κB signaling pathway [J]. Tianjin Medical Journal, 2026, 54(3): 232-237.
[2]	WANG Zhe, QIU Lin, MA Ben. Research on the effect of tomato derived nanovesicles on oral squamous cell carcinoma [J]. Tianjin Medical Journal, 2026, 54(2): 145-150.
[3]	ZHAO Lanjun, LI Lianghui, MA Xin, GONG Jiaojiao, ZHENG Chenhui, SHI Lin. The effect of andrographolide regulating STAT3/GPX4 pathway on proliferation and apoptosis of myeloma cells [J]. Tianjin Medical Journal, 2026, 54(1): 8-13.
[4]	LIU Hong, ZHANG Yueyue, WANG Yilin, WANG Caili, WANG Xiaomin, MAO Min, LI Yan. The research on the mechanism of microRNA-34a influencing the progression of chronic lymphocytic leukemia by regulating the Wnt pathway [J]. Tianjin Medical Journal, 2025, 53(8): 785-790.
[5]	HAN Jiancun, ZHOU Yi. Effects of nobiletin on proliferation and apoptosis of laryngeal squamous cell carcinoma cells by regulating the FAK/AKT signaling pathway [J]. Tianjin Medical Journal, 2025, 53(6): 561-565.
[6]	YU Zhaoxia, MA Ben, QIU Lin, GAO Qian, NI Na. Elucidation of the anti-head and neck squamous cell carcinoma mechanism of Phellinus baumii polyphenol based on network pharmacology and experimental verification [J]. Tianjin Medical Journal, 2025, 53(5): 456-461.
[7]	LI Chen, LI Zhan’en, SU Hongwei, HOU Caiyun, DONG Shaowen. Effects of KRT17 regulating Wnt/β-catenin signaling pathway on proliferation, apoptosis and epithelial mesenchymal transformation of bladder cancer cells [J]. Tianjin Medical Journal, 2025, 53(5): 462-467.
[8]	SU Hongjian, ZHANG Chunyan, ZHANG Weidong, HAN Li, QIAO Yahong. Irisin affects the proliferation and migration of lung adenocarcinoma cells by regulating the EBF3/ALOX15 pathway [J]. Tianjin Medical Journal, 2025, 53(4): 337-342.
[9]	QI Weihua, HUANG Guanglei, ZHANG Yuanyuan, BAN Hongying, MAO Zhaoxu. Effect of forsythigenin on the malignant progression of lung cancer cells by regulating the cAMP/EPAC1/RAP1 signal pathway [J]. Tianjin Medical Journal, 2025, 53(4): 343-348.
[10]	YAN Lingxin, LI Sen, GUO Gaili, MENG Wanqiu, XU Chao. Isovitexin regulates proliferation, migration and invasion of pancreatic cancer cells via the miR-339-5p/HSPA8 axis [J]. Tianjin Medical Journal, 2025, 53(3): 230-235.
[11]	MA Lili, LI Zimu, WANG Liang, XU Peng, LI Xiumei. Effects of mesenchymal stem cell exosomes on biological behavior of esophageal carcinoma ECA109 cells [J]. Tianjin Medical Journal, 2025, 53(2): 113-117.
[12]	WANG Jian, CHENG Xianyong, YU Ning. The impact of miR-1247-5p/Smad2 axis on gastric cancer cell migration, invasion and epithelial-to-mesenchymal transition [J]. Tianjin Medical Journal, 2025, 53(2): 118-123.
[13]	XIE Yindong, ZHOU Ying, LI Yanping, NIU Yajing, SU Qichao. The effect of dexmedetomidine on the biological behavior of gallbladder cancer cells by regulating the CCL2-CCR2 pathway [J]. Tianjin Medical Journal, 2025, 53(12): 1233-1240.
[14]	YANG Jian, LI Min, LI Yueyang, TIAN Chen. T-ALL derived bone marrow stromal stem cells promote T-ALL proliferation through the FGF2-FGFR2 pathway [J]. Tianjin Medical Journal, 2025, 53(1): 29-34.
[15]	GAO Rui, ZHOU Guanen, HONG Yan, YAN Yan. Effect of protein tyrosine phosphatase receptor R-type on malignant biological behavior of glioma cells [J]. Tianjin Medical Journal, 2025, 53(1): 9-13.